Kinesins and Cancer 2015
DOI: 10.1007/978-94-017-9732-0_10
|View full text |Cite
|
Sign up to set email alerts
|

Kif14: A Clinically Relevant Kinesin and Potential Target for Cancer Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
12
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 6 publications
(13 citation statements)
references
References 66 publications
1
12
0
Order By: Relevance
“…We show that the overexpression of Kif14 accelerates tumor onset and increases tumor burden and tumor proliferation rate in the TAg‐RB retinoblastoma model. This provides strong evidence that KIF14 is indeed an oncogene, when considered in concert with previous clinical, in vitro and xenograft findings …”
Section: Discussionsupporting
confidence: 78%
See 4 more Smart Citations
“…We show that the overexpression of Kif14 accelerates tumor onset and increases tumor burden and tumor proliferation rate in the TAg‐RB retinoblastoma model. This provides strong evidence that KIF14 is indeed an oncogene, when considered in concert with previous clinical, in vitro and xenograft findings …”
Section: Discussionsupporting
confidence: 78%
“…Increased proliferation of Kif14 overexpressing tumor cells is consistent with previous in vitro work. Overexpression of KIF14 in hepatocellular carcinoma, lung and ovarian cancer cell lines markedly increased their proliferation capacity, and a similar effect was seen in immortalized mammary epithelial cells . It will be interesting to assess if Kif14 loss in the context of TAg‐RB would slow tumor growth, as it does in cell and xenograft models.…”
Section: Discussionmentioning
confidence: 85%
See 3 more Smart Citations